Janus kinase inhibitors (JAKis) are an important treatment option for people with chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohn's disease or ulcerative colitis. Since ...
Adolescents with alopecia areata achieve hair regrowth with 80% or more of scalp coverage while taking the Janus kinase inhibitor baricitinib, a phase 3 study finds.
News Medical on MSN1d
Understanding how JAK inhibitors may increase blood clot riskWhy do medications that are supposed to help patients with chronic inflammatory diseases sometimes lead to blood clots?
1d
News-Medical.Net on MSNExperts release new guidelines on JAK inhibitors for chronic inflammatory diseasesJanus kinase inhibitors (JAKis) are an important treatment option for people with chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohn's disease or ulcerative colitis.
Janus kinase inhibitor cycling may be more effective than switching to bDMARDs among patients with RA who had an inadequate response to initial JAK inhibitor therapy.
Patients with atopic dermatitis were at greater risk for serious infection after initiating Janus kinase inhibitors vs Th2 cytokine inhibitors.
Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "Janus Kinase (JAK) Inhibitor - Pipeline Insight, 2025" drug pipelines has been added to ResearchAndMarkets.com's offering. The "Janus Kinase (JAK ...
19d
MedPage Today on MSNOff-the-Shelf Drugs May Treat This New Autoimmune DiseaseJanus kinase (JAK) inhibitors look to be a good treatment option for the newly recognized, rare autoimmune disease known as SOCS1 insufficiency, researchers found. Which was not exactly a surprise.
The "Janus Kinase (JAK) Inhibitor - Pipeline Insight, 2025" drug pipelines has been added to ResearchAndMarkets.com's offering. The "Janus Kinase (JAK) Inhibitor- Pipeline Insight, 2025" report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results